This page will host Events plug-in for all Clarion and trade events.

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Bavarian Nordic R/I ADR (OP:BVNRY)

9.674 -0.056 (-0.57%)

Streaming Delayed Price Updated: 10:30 AM EDT, Apr 24, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,120
Open	9.674
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	9.730
Today's Range	9.674 - 9.674
52wk Range	7.630 - 13.00
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

May 16, 2025

Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat ↗

September 17, 2024

The UK government has purchased 150,000 mpox vaccine doses from Bavarian Nordic, enhancing its response to clade I mpox, while partnering with WHO and UNICEF.

Via Benzinga

Performance

YTD	-3.5%	-3.5%
1 Month	-0.2%	-0.2%
3 Month	-7.3%	-7.3%
6 Month	-22.5%	-22.5%
1 Year	+26.0%	+26.0%

More News

Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows ↗

September 06, 2024

Via Benzinga

UPDATE - International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025

May 08, 2025

From Virtual Investor Conferences

Via GlobeNewswire

Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic ↗

September 06, 2024

Via Benzinga

WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped' ↗

August 26, 2024

Via Benzinga

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025

May 08, 2025

From Virtual Investor Conferences

Via GlobeNewswire

Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain ↗

August 26, 2024

Via Benzinga

GeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?

August 20, 2024

Via MarketBeat

3 Promising Vaccine Stocks To Watch In The Event Of A Mpox Surge ↗

August 19, 2024

Via Talk Markets

Mpox Variant Sparks Global Concern As Europe, China Ramp Up Screening ↗

August 19, 2024

Via Benzinga

Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency ↗

August 16, 2024

Via Benzinga

Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On? ↗

August 15, 2024

Via Benzinga

WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak ↗

August 14, 2024

Via Benzinga

Bavarian Nordic Beefs Up Chikungunya Vaccine Race With Valneva With Encouraging Late-Stage Trial Data ↗

June 20, 2023

Via Benzinga

Deutsche Bank ADR Investor Conference: Presentations Now Available for Online Viewing

May 18, 2023

From Virtual Investor Conferences

Via GlobeNewswire

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 16th and 17th, 2023

May 09, 2023

From Virtual Investor Conferences

Via GlobeNewswire

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 16th and 17th, 2023

May 15, 2023

From Virtual Investor Conferences

Via GlobeNewswire

Monkeypox Vaccine Maker Bavarian Nordic Bets $380M On Emergent Bio's Travel Vaccines ↗

February 15, 2023

Via Benzinga

Emergent BioSolutions Announces Sale of Travel Health Business to Bavarian Nordic for Up To $380 Million

February 15, 2023

From Emergent BioSolutions

Via GlobeNewswire

West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies ↗

December 15, 2022

Via Benzinga

Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa ↗

November 03, 2022

Via Benzinga

White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox ↗

September 02, 2022

Via Benzinga

Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed ↗

August 26, 2022

Via Benzinga

SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report ↗

August 25, 2022

Via Benzinga

Frequently Asked Questions

Is Bavarian Nordic R/I ADR publicly traded?

Yes, Bavarian Nordic R/I ADR is publicly traded.

What exchange does Bavarian Nordic R/I ADR trade on?

Bavarian Nordic R/I ADR trades on the OTC Traded

What is the ticker symbol for Bavarian Nordic R/I ADR?

The ticker symbol for Bavarian Nordic R/I ADR is BVNRY on the OTC Traded

What is the current price of Bavarian Nordic R/I ADR?

The current price of Bavarian Nordic R/I ADR is 9.674

When was Bavarian Nordic R/I ADR last traded?

The last trade of Bavarian Nordic R/I ADR was at 04/24/26 10:30 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.